Bactobio
Bactobio uses synthetic biology, next-generation sequencing, and machine learning to culture microbes.
Bactobio has raised €7.0M across 1 funding round from 3 investors, most recently a round in Dec 2022. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.bacto.bio ↗
Total raised
€7.0M
€6,969,855
Funding rounds
1
Investors
3
distinct backers
Active since
2022-12
latest 2022-12
Funding by year
EUR raised per yearBactobio — funding by year — interactive chart.
Data table
| Bactobio — funding by year | |
|---|---|
| 2022 | €7.0M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-05 | Other | €7.0M | Bridford Group,Hugh Grant,Peder Holk Nielsen | View deal → |
Related news
- London-based biotech company Bactobio raises €6.9M: Know moresiliconcanals.com · 2022-12
Similar companies
same sector or countryGlobal coverage: FundingData